Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Doecke

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Plos One|August 23, 2012
Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivationNigel A Morrison, Alexandre A Stephens, Motomi Osato, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Science Advances|February 1, 2021
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's diseaseYu-Hui Liu, Jun Wang, Qiao-Xin Li, et al.
Journal of Neuroimmunology|June 9, 2014
An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulationAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2026
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative reviewBhargav Tallapragada, Shaun J Markovic, Kieran J Marston, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentRosita Shishegar, Pierrick Bourgeat, Vincent Dore, et al.
Acta Neuropathologica|July 15, 2016
Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's diseaseBen J Gu, Xin Huang, Amber Ou, et al.
Research Square|November 24, 2025
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Ebiomedicine|June 12, 2026
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Plos One|August 23, 2012
Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivationNigel A Morrison, Alexandre A Stephens, Motomi Osato, et al.
Metallomics : Integrated Biometal Science|March 29, 2014
Decreased serum zinc is an effect of ageing and not Alzheimer's diseaseAlan Rembach, Dominic J Hare, James D Doecke, et al.
Science Advances|February 1, 2021
Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's diseaseYu-Hui Liu, Jun Wang, Qiao-Xin Li, et al.
Journal of Neuroimmunology|June 9, 2014
An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulationAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2026
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative reviewBhargav Tallapragada, Shaun J Markovic, Kieran J Marston, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentRosita Shishegar, Pierrick Bourgeat, Vincent Dore, et al.
Acta Neuropathologica|July 15, 2016
Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's diseaseBen J Gu, Xin Huang, Amber Ou, et al.
Research Square|November 24, 2025
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Ebiomedicine|June 12, 2026
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 12